Cellectis plant sciences, Inc. Company Profile

13:42 EDT 23rd June 2018 | BioPortfolio

News Articles [1245 Associated News Articles listed on BioPortfolio]

Cellectis closes $164.5mm public ADS sale

Cellectis SA (immunotherapies for cancer) netted $164.5mm through a follow-on public offering of 5.6mm American Depositary Shares (representing 5.6mm ordinary shares) at $31. Funds will help the compa...

Elsy Boglioli named as COO successor at Cellectis

French biotech company Cellectis announced today that Dr Mathieu Simon is retiring as executive vice…

Cellectis CEO Provides Update on UCART Programs and ‘Laser Focus’ of Company in 2018

After a brief stumble with UCART123 that resulted in a clinical hold last year, Cellectis is moving on with its study.

After settling lawsuit with Bayer, Cellectis spin-off launches €41M follow-on offering

Cellectis spin-off Calyxt has launched a €41M follow-on round after settling the lawsuit it recently brought against Bayer CropScience, for breach of a license agreement for access to patents for...

Protocol revisions announced for trial of Cellectis' leukemia CAR-T candidate

Several protocol changes were made by Cellectis in an effort to advance its Phase I study for its chimeric antigen receptor T -More- 

Cellectis files IND to start Phase I trial for B-cell leukemia candidate

Cellectis submitted an investigational new drug application to the FDA seeking approval to begin its early-stage trial to ass -More- 

Cellectis Snags $164 Million in IPO to Advance CAR-T Programs

Cellectis has found some sure financial footing that will support its efforts through the remainder of the year. The company secured $163.7 million in an initial public offering to develop CART-T prod...

Cellectis submits IND to US FDA for ‘off-the-shelf’ UCART22

Cellectis has submitted an IND for off-the-shelf T-cell candidate UCART22, an allogeneic investigational therapy designed to treat leukemia.

PubMed Articles [2052 Associated PubMed Articles listed on BioPortfolio]

Dimensionless Numbers for Plant Biology.

Dimensionless numbers are ubiquitous in the physical sciences because they provide insight into physical processes, organize large quantities of data, facilitate 'scale analysis' and establish 'simila...

A Three-Locus, PCR-based Method for Forensic Identification of Plant Material.

Plant residue is currently an underutilized resource in forensic investigations despite the fact that many crime scenes, as well as suspects and victims, harbor plant-derived residue that could be rec...

Plant Growth Promoting and Biocontrol Activity of Streptomyces spp. as Endophytes.

There has been many recent studies on the use of microbial antagonists to control diseases incited by soilborne and airborne plant pathogenic bacteria and fungi, in an attempt to replace existing meth...

Plant Defenses against Herbivory: Closing the Fitness Gap.

Many morphological and chemical features of plants are classified as plant defenses against herbivores. By definition, plant defenses should increase a plant's fitness (i.e., its contribution to the g...

Action of steroids and plant triterpenoids on CatSper Ca2+ channels in human sperm.

Clinical Trials [417 Associated Clinical Trials listed on BioPortfolio]

The Influence of Dietary Plant Sterols and Plant Stanols on Cholesterol and Plant Sterol Levels in Atheromatous Plaques

This study aims to explore whether the increased supply of dietary plant sterols and plant stanols have any influence on serum levels of phytosterols and on consistency of carotid atheroma...

Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks

The aim is to investigate the effects of yoghurt drinks containing two doses of plant stanol ester either with or without added camelina oil on the serum cholesterol levels in moderately h...

Dietary Phytosterols and Human Aortic Valve

This randomized controlled double-blind intervention study unravels influence of dietary plant sterols and stanols on the structure and the sterol composition of the human aortic valve. Th...

Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients

This study evaluates the addition of medicinal plant in the treatment of diabetic foot keratosis. Half of participants will receive medicinal plant and other half will receive a placebo.

Field Evaluation of Plant-Based Mosquito Control

Isolated minority communities in China use traditional plant-based methods of mosquito control. This study is evaluating 4 plants used in this way by monitoring mosquitoes entering houses...

Companies [1471 Associated Companies listed on BioPortfolio]

Cellectis plant sciences, Inc.


Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools, meganucleases. These molecular scissors enable targeted modifications ...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

Cellectis bioresearch

Cellectis bioresearch was incorporated as a subsidiary of Cellectis SA (Alternext: ALCLS) in June 2008. It provides life science researchers with ready-to-use research tools for genome customization. ...

Cellectis S.A.

Cellectis S.A. is a world leader in genome engineering and genome surgery. The company focuses on developing and producing custom meganucleases for use in in vivo genome surgery a...

More Information about "Cellectis plant sciences, Inc." on BioPortfolio

We have published hundreds of Cellectis plant sciences, Inc. news stories on BioPortfolio along with dozens of Cellectis plant sciences, Inc. Clinical Trials and PubMed Articles about Cellectis plant sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cellectis plant sciences, Inc. Companies in our database. You can also find out about relevant Cellectis plant sciences, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record